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Total Sitting Time and Sitting Pattern in Postmenopausal Women
Differ by Hispanic Ethnicity and are Associated With Cardiometabolic
Risk Biomarkers
Ya-Ju Chang, PhD; John Bellettiere, MA, MPH, PhD; Suneeta Godbole, MPH; Samaneh Keshavarz, BS; Joseph P. Maestas;
Jonathan T. Unkart, MD, MPH, MS; Daniel Ervin, PhD; Matthew A. Allison, MD, MPH; Cheryl L. Rock, PhD, RD; Ruth E. Patterson, PhD;
Marta M. Jankowska, PhD; Jacqueline Kerr, PhD; Loki Natarajan, PhD; Dorothy D. Sears, PhD
Background-—Sedentary behavior is pervasive, especially in older adults, and is associated with cardiometabolic disease and
mortality. Relationships between cardiometabolic biomarkers and sitting time are unexplored in older women, as are possible
ethnic differences.
Methods and Results-—Ethnic differences in sitting behavior and associations with cardiometabolic risk were explored in
overweight/obese postmenopausal women (n=518; meanSD age 636 years; mean body mass index 31.44.8 kg/m2).
Accelerometer data were processed using validated machine-learned algorithms to measure total daily sitting time and mean
sitting bout duration (an indicator of sitting behavior pattern). Multivariable linear regression was used to compare sitting among
Hispanic women (n=102) and non-Hispanic women (n=416) and tested associations with cardiometabolic risk biomarkers.
Hispanic women sat, on average, 50.3 minutes less/day than non-Hispanic women (P<0.001) and had shorter (3.6 minutes less,
P=0.02) mean sitting bout duration. Among all women, longer total sitting time was deleteriously associated with fasting insulin
and triglyceride concentrations, insulin resistance, body mass index and waist circumference; longer mean sitting bout duration
was deleteriously associated with fasting glucose and insulin concentrations, insulin resistance, body mass index and waist
circumference. Exploratory interaction analysis showed that the association between mean sitting bout duration and fasting
glucose concentration was significantly stronger among Hispanic women than non-Hispanic women (P-interaction=0.03).
Conclusions-—Ethnic differences in 2 objectively measured parameters of sitting behavior, as well as detrimental associations
between parameters and cardiometabolic biomarkers were observed in overweight/obese older women. The detrimental association
between mean sitting bout duration and fasting glucose may be greater in Hispanic women than in non-Hispanic women.
Corroboration in larger studies is warranted. ( J Am Heart Assoc. 2020;9:e013403. DOI: 10.1161/JAHA.119.013403.)
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S edentary behavior, characterized by sitting with energyexpenditure <1.5 metabolic equivalents, has a strong
associationwithweight gain,metabolic syndrome, type 2 diabetes
mellitus, and cardiovascular disease.1–4 Excessive sedentary
behavior has become a common feature of life for many adults
who live in developed nations with advanced technologies.5,6
Objective measurement of amount and patterns of sitting can be
used to describe individuals’ sitting habits; 2 common measures
include total sitting time and mean sitting bout duration. The
former reflects the volumeof sitting timeaccruedper daywhile the
latter accounts for how that sitting time is accumulated, be it in
short, frequently interrupted sitting bouts or in long, unbroken
bouts of sitting.7 Detrimental associations of excessive sitting
time and of uninterrupted, prolonged sitting patterns with
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cardiometabolic factors have been demonstrated in multiple
cross-sectional, longitudinal, and experimental studies, often
independent of physical activity.4,8–13 These findings indicate that
sedentary behavior, including total sitting time and mean sitting
bout duration, are relevant to personal and public health.
In the United States, adults aged >60 years comprise the
population with the highest rates of sedentary behavior.6 Across
the lifespan and between sexes, women appear to accumulate
more sedentary time thanmenbefore the age of30 years, a trend
which appears to reverse for those aged ≥60 years.6 Although
less sedentary than men of matched age, older women have
increased risk for cardiovascular disease (CVD) following
menopause as levels of cardioprotective estrogen decline. The
identification of mutable lifestyle factors that can prevent or
delay CVD onset is especially important among postmenopausal
women. Early studies that relied on self-report of sitting time
showed a dose-dependent relationship between total sitting time
and cardiovascular disease mortality in older women.14 A follow-
up study using data from accelerometers found that both total
sedentary time and sedentary time accumulated in prolonged
patterns were associated with increased risk for CVD.11 This
highlights the importance of characterizing total sitting time and
patterns of sitting with respect to cardiovascular risk among
postmenopausal women.
While CVD mortality is the leading cause of death in the
United States, large racial/ethnic disparities in cardiovascular
health exist between Hispanic and non-Hispanic populations.
Compared with non-Hispanic whites, Hispanics have worse
measures of overall cardiovascular health, but surprisingly
experience lower CVD mortality rates.15 With the growing
Hispanic population in theUnited States, it is important to study
potential behavioral factors related to disparities in CVD risk
biomarkers. To accomplish this, we examined total sitting time
and patterns of sitting time, determined using accelerometer
measures and validated machine-learned algorithms, and their
relationship to cardiometabolic risk biomarkers in overweight/
obese Hispanic and non-Hispanic postmenopausal women.
Methods
The data that support the findings of this study are available
from the corresponding author upon reasonable request.
Sample and Design
This cross-sectional study was designed to assess associations
of total sitting time and patterns of sitting time with
cardiometabolic biomarkers in overweight/obese post-
menopausal women. Archival data used in the current analysis
were combined from 3 separate studies that used identical
accelerometers, accelerometer wear protocols, and accelerom-
eter data processing protocols. Signed informed consent was
obtained from all participants enrolled in each of the 3 studies.
Data from women enrolled in the following 3 clinical studies
who were aged ≥55 years and had a body mass index (BMI) at
least 25 kg/m2 were included (n from each parent study
included in our analysis is noted): Community of Mine (a cross-
sectional study of community-living people residing in San
Diego County)16 (n=128) and 2 randomized control trials, The
MENU (Metabolic, Exercise and Nutrition at University of
California, San Diego [UCSD]) study17,18 (n=95) and The Reach
for Health study19 (n=295). Women with diabetes were
ineligible for the MENU and Reach for Health studies. Women
with type 2 diabetes (but not type 1 diabetes) were eligible for
the Community of Mine study, but none included in the current
analysis who were insulin users (n=6) had taken insulin the
morning of their fasting blood draw. Data used in the current
analysis were collected at baseline timepoints for the 2
randomized control trials and, from all 3 studies, were critical
for enrollment of participants, which resulted in low missing-
ness (see footnote in Table 2). All studies have undergone
review and approval through UCSD Institutional Review Board.
Cardiometabolic Biomarkers
BMI, waist circumference, fasting glucose, fasting insulin,
homeostatic model assessment of insulin resistance index
(HOMA-IR), and HOMA2-IR were primary outcomes of this
Clinical Perspective
What Is New?
• Significant differences in total sitting time and mean sitting
bout duration (an indicator of sitting behavior pattern) were
observed between overweight/obese postmenopausal His-
panic and non-Hispanic women wherein Hispanic women,
on average, spent 9% fewer minutes sitting per day and had
9% shorter sitting bout durations.
• Among overweight/obese postmenopausal Hispanic and
non-Hispanic women, we observed that sitting behavior
(total sitting time and mean sitting bout duration) was
deleteriously associated with higher levels of car-
diometabolic risk biomarkers (body mass index, waist
circumference, fasting glucose, insulin, and triglycerides,
and insulin resistance).
What Are the Clinical Implications?
• Clinicians and other healthcare providers should encourage
patients to reduce their sitting time intervals, in addition to
encouraging physical activity.
• Targeting sitting behaviors may benefit cardiometabolic
health in overweight/obese postmenopausal women.
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study as they were measured in all 3 parent studies. Total
cholesterol, low-density lipoprotein (LDL) cholesterol, high-
density lipoprotein (HDL) cholesterol, and triglycerides were
analyzed as secondary outcome measures, as lipid panel
blood tests were conducted only in the MENU and Commu-
nity of Mine studies, not in the Reach for Health study.
Collection of anthropometric data and fasting blood from
participants in the 3 parent studies has been described
previously, as have the methods for fasting glucose and
insulin measurements for Reach for Health and measure-
ment of all MENU biomarkers.16,18–20 Body mass index (BMI;
computed as kg/m2) was determined measuring weight and
height with a calibrated scale and stadiometer, respectively.
Waist circumference was measured using a fabric, non-
stretchable measuring tape. Glucose and insulin were
measured in EDTA plasma using identical assay methods
for Reach for Health and Community of Mine. Specifically,
the glucose oxidase method using a YSI 2900 Bioanalyzer
(Xylem, Inc.) in the Sears laboratory and using a Meso Scale
Discovery electrochemiluminescent immunoassay kit and
SECTOR Imager 2400 (Meso Scale Discovery, Inc.) at the
UCSD ACTRI Biomarker Laboratory, respectively. Insulin was
measured in serum in the MENU study using the ADVIA
Centaur double antibody immunoassay with chemilumines-
cent detection at Arup Laboratories (Salt Lake City, UT).
Glucose, total cholesterol, HDL-cholesterol, and triglycerides
were measured in serum in the MENU study using the Kodak
Ektachem Analyzer system (Johnson & Johnson Clinical
Diagnostics). In the Community of Mine study, total choles-
terol, HDL-cholesterol, and triglycerides were measured in
plasma at the UCSD Center for Advanced Laboratory
Methods, a CLIA-certified diagnostic laboratory for the UCSD
Health System. LDL cholesterol values for both MENU and
Community of Mine studies were calculated using the
Friedewald equation.21 Fasting glucose and insulin concen-
trations were used to calculate the homeostatic model
assessment of insulin resistance index (HOMA-IR; [fasting
glucose, mmol/L]9[insulin, mIU/L]/22.5) and HOMA2-IR,
which is a model-derived estimate of insulin resistance
calculated using the HOMA2 calculator.22,23
Sitting and Activity Measures
Participants wore ActiGraph GT3X+ accelerometers on their
right hip for up to 14 days, removing devices only to sleep and
when showering or swimming. Participants who did not meet
the recommended wear protocol of at least 4 days (Reach for
Health and MENU) or 7 days (Community of Mine) with ≥10
hours of accelerometer wear were asked to re-wear the
devices. Of the total sample, 99% (n=516) had the recom-
mended24 4 days with ≥10 hours of accelerometer wear and
the remaining participants had at least 2 days with >13.5
hours of wear. Acceleration was measured 30 times per
second and the 30 Hz accelerometer data were processed
with a machine-learned random forest classifier that was
specifically designed and validated for assessing sitting and
moving behaviors in older women.25,26 The random forest
classifier was originally trained and validated using coded
images from cameras worn around the neck of 39 community-
living women, then validated in 2 separate samples.27 The
algorithms were trained to measure free-living behaviors using
data collected during free-living conditions. The R software
package of these algorithms developed by Katherine Ellis PhD
is freely available (https://cran.r-project.org/web/package
s/TLBC/TLBC.pdf). Sitting (not in a vehicle) had sensitivity of
89% and specificity of 91% compared with annotated images;
sitting in a vehicle had 84% sensitivity and 99% specificity.25
Accelerometer non-wear was identified using the Choi
algorithm using a 90-minute frame, 30-minute stream frame,
and 2-minute tolerance.28 All sitting was combined then
averaged across adherent days (at least 10-h/day of
accelerometer wear, recommended protocol for older
adults24) to measure total sitting time. Consecutive minutes
spent sitting were classified as sitting bouts (with no
minimum and no tolerance) and the mean sitting bout
duration was computed across all adherent days to measure
sitting patterns, with higher values indicating prolonged
patterns and lower values indicating interrupted patterns. To
measure moderate-to-vigorous physical activity (MVPA), 30 Hz
data were integrated to counts per minute (cpm) using the low
frequency extension filter in ActiLife v6.0. The average
minutes per day with ≥1952 cpm was used to measure time
in MVPA. For sensitivity analyses, we also averaged time
spent walking (from the machine learning classifier) as a proxy
for MVPA and time spent sedentary (by the commonly used
100 cpm cut point applied to the vertical axis24) over all
adherent days.
Covariates
Covariates included education (high school graduate or less;
some college/vocational training; and college graduate),
marital status (married/living together and not married),
race/ethnicity (Hispanic and non-Hispanic), and physical
functioning. Physical functioning was measured in Reach for
Health and MENU studies using the 10-item subscale from the
Short Form-36 (SF-36). The SF-36 was not administered in
the Community of Mine study, so we used the 14-items from
the Late Life Functioning and Disability Index,29 which was
administered in Community of Mine. Results from both
measures (SF-36 and Late Life Functioning and Disability
Index), which have similar items and have been shown to be
highly correlated,30 were harmonized for this combined cohort
analysis by placing each item on a measurement scale from 0
DOI: 10.1161/JAHA.119.013403 Journal of the American Heart Association 3
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to 100 with higher numbers indicating better functioning. The
scores were averaged across all items in the measures (SF-36
or Late Life Functioning and Disability Index) for each
participant to give a single physical functioning score.
Statistical Analysis
An objective of this study was to examine sedentary behavior
and cardiometabolic health in Hispanic women versus non-
Hispanic women. Accordingly, we summarized data for the full
sample and separately for Hispanic women and non-Hispanic
women. Each cardiometabolic outcome was log transformed
then modeled using successively adjusted linear regression
analyses with total sitting time and mean sitting bout duration
evaluated in separate models. Complete case analysis was
used. Model 1 was adjusted for age and accelerometer wear
time; Model 2 (our main model) was additionally adjusted for
Hispanic ethnicity (yes/no), education, marital status, phys-
ical functioning, and a variable for the original study from
which women were recruited (ie, the parent study). Then, to
assess whether associations were present after adjustment
for MVPA—which has been conceptualized as a confounder, a
mediator, an effect modifier, and a competing behavior (eg,
using a compositional or isotemporal framework) in previous
studies31–33—Model 3a additionally adjusted for MVPA.
Model 3b further adjusted for BMI, which could be in the
causal pathway between sedentary behavior and car-
diometabolic biomarkers. We tested the assumptions of
homoscedasticity by reviewing plots of residuals and no
violations were observed.
We were also interested in evaluating whether associations
of sedentary behavior and cardiometabolic biomarkers dif-
fered among Hispanic women and non-Hispanic women. To
accomplish this, our main model (model 2) was repeated
separately among Hispanic women and non-Hispanic women
to show trends. Formal tests for effect modification were
conducted by including a multiplicative interaction term
(exposure*Hispanic) in model 2 within the full sample and
because of the exploratory nature of this investigation,
statistical significance set to P<0.10. In a post-hoc analysis,
we also examined effect modification of associations between
sitting time measures and glycemic control biomarkers by
BMI status, the statistical significance threshold was set to
P<0.10.
Sensitivity Analyses
To test whether associations differed by parent study, we
evaluated effect measure modification by including the
multiplicative interaction term in model 2 and by comparing
beta coefficients that were separately estimated for each
study. We also repeated model 2 with both sedentary
behavior variables (total sedentary time and mean bout
duration) measured using the 100 cpm threshold. Finally, we
repeated Model 3a by replacing MVPA with the machine-
learned measure of daily walking time.
Results
Table 1 shows the participant characteristics of the overall
sample and separately for Hispanic and non-Hispanic women.
The meanSD age of the sample was 63.45.9 years, 62%
were married, and just over half (51%) had completed a
college education. On average, Hispanic women had lower
education, physical functioning, waist circumference, and HDL
cholesterol and higher fasting plasma glucose and LDL
cholesterol than did non-Hispanic women. Hispanic women
sat for an average of 50795 minutes per day (8.5 hours) in
bouts of 36.413.9 minutes while non-Hispanic women sat
for an average of 55791 minutes per day (9.3 hours) in
bouts of 40.015.8 minutes. Using a multivariable-adjusted
model (adjusting for age, physical functioning, education, and
Hispanic ethnicity), there were differences in total sitting and
sitting patterns between non-Hispanic and Hispanic women;
Hispanic women spent 50.3 fewer minutes sitting per day
(P<0.001) and had shorter sitting bout durations by 3.6
minutes (P=0.02).
Table 2 shows associations of total sitting time and mean
sitting bout duration with BMI, waist circumference, fasting
glucose, fasting insulin, and HOMA-IR. In models adjusted for
age, accelerometer wear time, Hispanic ethnicity, education,
marital status, physical functioning, and parent study, each
additional hour of sitting time was associated with a 1.56%
higher BMI (95% CI, 0.80–2.33), 1.71% higher waist circum-
ference (95% CI, 0.62–2.81), 6.38% higher fasting insulin (95%
CI, 2.86–10.02), and 7.27% higher HOMA-IR (95% CI, 3.35–
11.35) (P-trend<0.01 for all associations). Associations were
slightly attenuated after adjustment for MVPA, but the
significance of all associations persisted. For fasting insulin
and HOMA-IR, attenuation was also observed after adjust-
ment for BMI, but again, the overall patterns and statistical
significance of both associations persisted.
After multivariable adjustment, sitting bout duration was
significantly associated with BMI (1.64% [95% CI, 0.50%–
2.79%]; P-trend=0.005), waist circumference (1.93% [95% CI,
0.31%–3.57%]; P-trend=0.020), fasting glucose (1.36% [95%
CI, 0.06%–2.68%]; P-trend=0.041), fasting insulin (7.43% [95%
CI, 2.19%–12.95%]; P-trend=0.005), and HOMA-IR (8.92%
[95% CI, 3.05%–15.13%]; P-trend<0.01). The associations,
except with fasting glucose, were statistically significant after
MVPA adjustment. Only HOMA-IR (6.02% [95% CI, 0.56%–
11.77%]; P-trend=0.031) was significant with sitting bout
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Sitting and Cardiometabolic Risk in Older Women Chang et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
duration after further adjusting for BMI. Table S1 shows
regression modeling results for fasting lipid panel components
(total cholesterol, LDL cholesterol, HDL cholesterol, and
triglycerides), which were only measured in 2 of the 3 parent
studies, and HOMA2-IR (calculated for the full cohort).
The association between sitting bout duration and fasting
glucose was significantly stronger for Hispanic women than
for non-Hispanic women (P-interaction=0.03). An additional
15-minute longer mean sitting bout duration was associated
with a 4.8% higher fasting glucose level (95% CI, 0.50%–
Table 1. Demographics, Activity-Related Measures, and Cardiometabolic-Risk Biomarkers
Total (n=518) Hispanic (n=102) Non-Hispanic (n=416) P Value*
Age (y), mean (SD) 63.4 (5.9) 63.0 (5.4) 63.5 (6.1) 0.37
Race/ethnicity, n (%)
White 428 (89) 53 (73) 375 (92) <0.001†
Black 14 (3) 0 (0) 14 (3)
Native American 3 (1) 1 (1) 2 (0)
Asian 3 (1) 2 (3) 1 (0)
Pacific Islander 9 (2) 1 (1) 8 (2)
Other/Unknown 13 (3) 12 (16) 1 (0)
Mixed 9 (2) 4 (5) 5 (1)
Marital status, n (%)
Married/Living together 319 (62) 55 (54) 264 (63) 0.10
Single/Divorced/Widowed/Separated 199 (38) 47 (46) 152 (37)
Highest education level, n (%)
Up to high school completion 66 (13) 35 (34) 31 (7) <0.001†
Some college or vocation training 190 (37) 32 (31) 158 (38)
College graduate 262 (51) 35 (34) 227 (55)
Physical functioning, mean (SD)‡ 73.2 (23.5) 66.0 (27.7) 74.9 (22.0) 0.003†
Activity-related measures, mean (SD)§
Total sitting time; min/dk 547.4 (93.6) 507.1 (94.6) 557.4 (90.7) <0.001†
Mean sitting bout duration; min/d 39.2 (15.5) 36.4 (13.9) 40.0 (15.8) 0.02†
Moderate-to-vigorous activity; min/dk 21.2 (19.2) 22.2 (19.2) 20.9 (19.2) 0.55
Walking time; min/dk 61.1 (40.0) 59.2 (47.6) 61.5 (37.9) 0.65
Cardiometabolic biomarkers, mean (SD)
Body mass index; kg/m2 31.4 (4.8) 31.4 (4.8) 31.5 (4.8) 0.96
Waist circumference; cm 98.5 (15.3) 94.8 (20.1) 99.4 (13.8) 0.03†
Fasting glucose; mg/dL¶ 104.0 (21.2) 109.0 (29.1) 102.7 (18.6) 0.04†
Fasting insulin; pg/mL¶ 529.3 (329.5) 577.6 (381.0) 517.6 (315.2) 0.15
HOMA-IR¶ 3.9 (3.1) 4.6 (3.7) 3.8 (2.9) 0.06
HOMA2-IR¶ 2.0 (1.3) 2.2 (1.5) 2.0 (1.2) 0.11
Fasting LDL cholesterol; mg/dL# 119.6 (33.6) 113.1 (30.3) 122.5 (34.7) 0.05
Fasting HDL cholesterol; mg/dL# 61.6 (15.3) 56.4 (12.0) 63.9 (16.0) <0.001†
Fasting triglycerides; mg/dL# 125.6 (71.7) 133.1 (78.0) 122.2 (68.7) 0.32
HDL indicates high-density lipoproteins; HOMA-IR, homeostatic model assessment of insulin resistance; LDL, low-density lipoproteins.
*P values computed using Chi-square tests for categorical variables and t tests for continuous.
†P<0.05.
‡Missing physical functioning data from 1 participant.
§Missing machine-learned data from 4 participants.
kVariables adjusted for accelerometer wear time.
¶Missing glycemic regulation biomarker data from 3 participants.
#Data available from Community of Mine and MENU participants only [n=220, 68 Hispanic].
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9.37%) in Hispanic women compared with a 0.9% higher level
(95% CI, 0.40%–2.22%) in non-Hispanic women (Figure).
Similar patterns of Hispanic/non-Hispanic differential associ-
ations were observed for insulin (P=0.42), HOMA-IR (P=0.22),
and waist circumference (P=0.46), but none met levels for
statistical significance. Interestingly, the association between
total sitting time and BMI was stronger for non-Hispanic
women (1.85% increase in BMI associated with 1 hour of
sitting time; 95% CI, 0.64%–3.07%) than for Hispanic women
(1.00%; 95% CI, 2.42%–3.95%; P-interaction=0.08). There
were no other ethnicity-related interactions with sitting time
or sitting bout duration and any other biomarker. Nearly all
associations of total sitting time and mean sitting bout
duration tested with glycemic regulation biomarkers were
stronger, P-interaction<0.1, among obese women (BMI ≥30
kg/m2) than for overweight women (BMI 25–29.9 kg/m2)
(Table 3).
We tested whether associations of total sitting time and
mean sitting bout duration with cardiometabolic biomarkers
differed across the parent studies to evaluate whether our
results were an artifact of combining data from 3 cohorts. No
significant differences were observed in the interaction P
values and the beta coefficients were not materially different
(data not shown). We repeated Model 2 using the most
Table 2. Associations of Total Sitting Time and Sitting Pattern With Cardiometabolic Risk Biomarkers
Total Sitting Time* Mean Sitting Bout Duration
% Difference† (95% CI) P Value % Difference† (95% CI) P Value
Body mass index
Model 1 2.08 (1.30 to 2.86) <0.001‡ 2.37 (1.18 to 3.58) <0.001‡
Model 2 1.56 (0.80 to 2.33) <0.001‡ 1.64 (0.50 to 2.79) 0.005‡
Model 3a 1.24 (0.45 to 2.04) 0.002‡ 1.26 (0.12 to 2.42) 0.031‡
Model 3b
Waist circumference
Model 1 2.82 (1.73 to 3.93) <0.001‡ 2.44 (0.77 to 4.13) 0.004‡
Model 2 1.71 (0.62 to 2.81) 0.002‡ 1.93 (0.31 to 3.57) 0.020‡
Model 3a 1.67 (0.51 to 2.83) 0.005‡ 1.80 (0.14 to 3.48) 0.034‡
Model 3b
Fasting glucose
Model 1 0.68 (0.17 to 1.54) 0.117 1.66 (0.36 to 2.97) 0.012‡
Model 2 0.83 (0.04 to 1.72) 0.063 1.36 (0.06 to 2.68) 0.041‡
Model 3a 0.69 (0.24 to 1.62) 0.145 1.21 (0.12 to 2.55) 0.076
Model 3b 0.70 (0.19 to 1.59) 0.126 1.21 (0.09 to 2.54) 0.070
Fasting insulin
Model 1 6.39 (2.95 to 9.95) <0.001‡ 6.51 (1.31 to 11.98) 0.014‡
Model 2 6.38 (2.86 to 10.02) <0.001‡ 7.43 (2.19 to 12.95) 0.005‡
Model 3a 5.12 (1.46 to 8.91) 0.006‡ 5.94 (0.68 to 11.48) 0.027‡
Model 3b 3.87 (0.57 to 7.27) 0.022‡ 4.72 (0.13 to 9.81) 0.057
HOMA-IR
Model 1 7.14 (3.30 to 11.13) <0.001‡ 8.29 (2.44 to 14.48) 0.005‡
Model 2 7.27 (3.35 to 11.35) <0.001‡ 8.92 (3.05 to 15.13) 0.003‡
Model 3a 5.85 (1.78 to 10.09) 0.005‡ 7.24 (1.36 to 13.46) 0.016‡
Model 3b 4.60 (0.91 to 8.43) 0.015‡ 6.02 (0.56 to 11.77) 0.031‡
Model 1 [n=511] is adjusted for age and accelerometer wear time. Model 2 [n=510] is adjusted for Model 1+education, marital status, physical functioning, ethnicity, and parent study.
Model 3a [n=510] is adjusted for Model 2+MVPA. Model 3b [n=510] is adjusted for Model 2+ body mass index. HOMA-IR indicates homeostatic model assessment of insulin resistance.
*Adjusted for accelerometer wear time using the residuals method.
†Estimates reflect the percentage difference in the geometric mean of each biomarker associated with a 60-minute increase in total sitting time or a 15-minute increase in mean sitting
bout duration.
‡P<0.05.
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common accelerometer data processing protocol to measure
sedentary time (vertical axis counts/minute <100) and
separately by replacing MVPA by a machine-learned variant
of the construct (walking time). Again, there were no
significant differences observed (data not shown).
Discussion
In this multi-cohort study of Hispanic and non-Hispanic
overweight/obese postmenopausal women, we observed that
sitting behavior (total sitting time and mean sitting bout
duration) was deleteriously associated with higher levels of
cardiometabolic risk biomarkers (BMI, waist circumference,
fasting glucose, insulin, insulin resistance, and triglycerides).
The persistence of associations between sitting behavior and
cardiometabolic risk factors after adjustment for MVPA or BMI
highlight the importance of sitting time and patterns on
cardiovascular health among overweight/obese post-
menopausal women. Although total daily sitting time and
mean sitting bout duration was shorter in Hispanic women
compared with non-Hispanic women in our population sample,
we observed a significant interaction between mean sitting
bout duration and fasting glucose among Hispanic women.
Sitting patterns may be an easy-to-target, modifiable lifestyle
factor for overweight/obese older women.
Prolonged sitting time is a common feature of modern
society at home and work involving television and hand-held
electronic device viewing, studying, desk work, computer
engagement, and leisure time activities.34 Numerous cross-
sectional studies demonstrate detrimental associations of
these behaviors with cardiometabolic outcomes and mortal-
ity.7 A 10-year longitudinal study showed that increases in
self-reported sitting time were detrimentally associated with
cardiometabolic risk biomarkers.35 Other dimensions of
Hispanic 
Non-Hispanic 
Hispanic 
Non-Hispanic 
Hispanic 
Non-Hispanic 
Hispanic 
Non-Hispanic 
Hispanic 
Non-Hispanic 
Hispanic 
Non-Hispanic 
Hispanic 
Non-Hispanic 
Hispanic 
Non-Hispanic 
Hispanic 
Non-Hispanic 
Hispanic 
Non-Hispanic 
BMI 
WC
Glucose 
Insulin 
HOMA-IR
% Difference (95% CI) 
0.71 (-2.42–3.95) 
1.85 (0.64–3.07) 
1.00 (-1.06–3.10) 
1.73 (0.90–2.56) 
4.52 (-1.89–11.34) 
1.64 (0.20–3.09)  
1.65 (-2.50–5.98) 
1.67 (0.69–2.66)  
4.84 (0.50–9.37)  
0.90 (-0.40–2.22) 
3.41 (0.60–6.31)  
0.56 (-0.33–1.47) 
15.85 (0.99–32.90) 
6.71 (1.12–12.60)  
8.46 (-0.94–18.75) 
6.68 (2.84–10.67)  
21.49 (4.01–41.90) 
7.69 (1.51–14.25)  
12.15 (1.23–24.24) 
7.30 (3.05–11.72)  
P-interaction
0.03
0.57
0.42
0.60
0.22
0.08
0.46
0.88
0.22
0.73
Mean Sitting Bout Duration 
Total Sitting Time 
10 20 4030-5 0
Figure. Associations of total sitting time and sitting pattern with cardiometabolic biomarkers among
postmenopausal Hispanic and non-Hispanic women. Model adjusted for age, accelerometer wear time,
education, marital status, physical function, and parent study. Red and white fill of symbols indicates
Hispanic and non-Hispanic populations, respectively. x-axis indicates the percentage difference in the
geometric mean of each biomarker associated with a 60-minute increase in total sitting time (triangle
symbols) or a 15-minute increase in mean sitting bout duration. P<0.10 are bold to highlight interactions
that are below a conservative threshold for statistical significance. BMI indicates body mass index; HOMA-
IR, homeostatic model assessment of insulin resistance; WC, waist circumference
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sitting pattern that are determined objectively by accelerom-
eter, including frequency of sit-to-stand transitions (breaks in
sedentary time) and prolonged bouts spent sitting (mean
sitting bout duration), are important features of sedentary
behavior to consider for cardiometabolic health. Three
population-based studies in adults from Australia, the United
States, and the United Kingdom demonstrated that a greater
number of breaks in sedentary time was beneficially associ-
ated with waist circumference, BMI, triglycerides, 2-hour
plasma glucose, and C-reactive protein.4,36,37 Other studies in
adults show that frequent interruption of sitting is associated
with better cardiometabolic health and lower fasting insulin
and HOMA-IR.9,13 Prolonged mean sedentary bout duration
was detrimentally associated with insulin, diastolic blood
pressure, waist circumference, triglycerides, and HDL choles-
terol measures among Canadian adults in the Health
Measures Survey and in US adults in the NHANES (National
Health and Nutrition Examination Survey) 2003/6.4,38,39
Interestingly, total sitting time and sitting patterns are not
always correlated within a population group and the various
dimensions of sitting behaviors may modify risk outcomes
differently. For example, in the NHANES 2003/6 study,
women accumulated more total sedentary time but also more
breaks in sitting than did men; yet, the women had better
cardiometabolic biomarker measures than did the men
(P<0.05; age and ethnicity/race adjusted).4 Overall, popula-
tion study-based findings are supported by experimental
laboratory studies demonstrating that frequent interruptions
of prolonged sitting time lead to improvements in metrics of
glycemic control and lipid metaboism.8,40–42
Objective measurement of sedentary time (accelerometer)
in US adults indicates that Mexican American adults have
sitting behaviors that are less detrimental for cardiometabolic
health (less sitting time per day, shorter mean sitting bouts,
more breaks in sitting per day) compared with non-Hispanic
white adults and tend to accumulate, on average, the lowest
overall sitting time among those from Hispanic/Latino
backgrounds.4,6,43 A cross-sectional study of Hispanic/Lati-
nos showed that higher levels of sedentary time and
sedentary patterns were deleteriously associated with HDL-
cholesterol, triglycerides, 2-hour glucose, fasting insulin, and
HOMA-IR and the relationships consistently appeared across
sex and age groups, highlighting the generalizability of
cardiometabolic risk associated with sedentary time.43,44
In comparing sedentary time effects on cardiometabolic
risk by race/ethnicity, there have been some differences
reported. Sedentary time has been reported to be significantly
related to higher waist circumference among non-Hispanic
whites but not Mexican Americans.4 In the present study,
although there was a similar magnitude of association in both
groups for total sitting time and BMI, we found a significant
interaction for non-Hispanic ethnicity. We did not find any
differential association of sitting time and waist circumference
by ethnicity but point estimates indicated stronger associa-
tions with prolonged sitting time among Hispanic women than
non-Hispanic women, which is the first time we are aware that
such a finding was reported. We detected a significant
interaction for Hispanic ethnicity with respect to mean sitting
bout duration association with fasting glucose. A large
longitudinal study (MESA [Multi-Ethnic Study of Atherosclero-
sis]) showed that increasing self-report sedentary behavior is
associated with incident type 2 diabetes, with variation across
race/ethnic groups.45 This study also showed less self-
reported sedentary behavior in Hispanics. We observed
stronger detrimental associations of sitting time patterns
with glucose, insulin, and HOMA-IR among obese women (BMI
≥30 kg/m2) compared with overweight women (BMI 25.0–
29.9 kg/m2). These findings are commensurate with previous
epidemiologic and experimental studies showing stronger
detrimental effects of sedentary behavior on metabolic health
among those who have worse cardiometabolic disease risk
factors.4,46–48
There are several strengths in our study. First, it focuses on
a homogeneous population of a certain age (≥55 years), sex
(all women), BMI (≥25 kg/m2), and race/ethnicity background
that has high cardiometabolic risk. Second, it uses a more
Table 3. Associations of Total Sitting Time and Sitting
Pattern With Glycemic Regulation Biomarkers: Tests of Effect
Modification by BMI Status
BMI 25 to 29.9 BMI ≥30
P-
Interaction
% Difference
(95% CI)*
% Difference
(95% CI)*
Total sitting time†
Fasting
glucose
0.24 (1.43, 0.97) 1.17 (0.07, 2.43) 0.16
Fasting
insulin
2.08 (3.18, 7.63) 5.06 (0.99, 9.29) 0.08‡
HOMA-IR 1.83 (3.87, 7.87) 6.32 (1.64, 11.22) 0.05‡
Mean sitting bout duration
Fasting
glucose
0.71 (2.56, 1.17) 1.99 (0.18, 3.83) 0.03‡
Fasting
insulin
1.36 (9.19, 7.14) 7.38 (1.41, 13.70) 0.03‡
HOMA-IR 2.06 (10.48, 7.15) 9.57 (2.65, 16.94) 0.02‡
Models [n=220 for body mass index 25–29.9; n=290 for body mass index ≥30] are
adjusted for age, education, marital status, physical functioning, Hispanic ethnicity, and
parent study. Of the body mass index ≥30 group, 24 (4.6%) had body mass index ≥40.
BMI indicates body mass index; HOMA-IR indicates homeostatic model assessment of
insulin resistance.
*Estimates reflect the percentage difference in the geometric mean of each biomarker
associated with a 60-minute increase in total sitting time or a 15-minute increase in
mean sitting bout duration.
†Adjusted for accelerometer wear time using the residuals method.
‡P-interaction<0.1.
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accurate classification of sitting posture than self-report or
simple accelerometry alone, based on objectively measured
physical activity refined by validated machine-learned algo-
rithms that determine sitting posture in the population we are
evaluating. Machine-learned algorithms trained using ground
truth data from the target population measured during free-
living conditions are thought to be more generalizable and
possibly more accurate for measuring actual behavior than
previously used data processing protocols that rely on cut
points, often developed in a laboratory setting. These study
findings can be uniquely leveraged to specifically target
sedentary lifestyle in high-risk subpopulations of minority, sex,
and age who have high potential for metabolic disorders and
poor cardiovascular health. Several limitations of this study
need to be noted. First, although we could control for
education level, dietary intake data were not available for all 3
parent studies so, we were unable to control for dietary
habits. Second, this is a cross-sectional analysis integrating
archival data from 3 separate clinical studies and as such can
only examine the association among elements but not
causality. Therefore, a more comprehensive interventional
study for cause-effect is needed to confirm the associations
of total sitting time and mean sitting bout duration with
cardiometabolic outcomes among older Hispanic and non-
Hispanic women. We are currently conducting 2 randomized
controlled sitting time intervention trials, Rise for Health (P01
AG052352, NCT #03473145) and Arriba por la Vida Estudio
(NCT #02905929) that will address these important ques-
tions.49 Third, in our modeling, we assumed additivity and
linearity of the specified confounding effects, thus residual
confounding attributable to non-linear associations may
persist. Finally, many tests were done for effect measure
modification and as a result the 1 significant finding related to
sitting bout duration and fasting glucose by Hispanic ethnicity
could be attributed to chance alone. Corroboration in other
studies is needed.
The findings in this study add to the body of evidence
showing detrimental cardiometabolic effects of sitting pat-
terns and extends the literature by showing associations in
Hispanic and non-Hispanic postmenopausal women. The
clinical implications that stem from this line of research
highlight an importance of expanding activity-related coun-
seling by physician and other public health practitioners from
a focus on exercise and MVPA to include improving sitting
habits with respect to both the total amount of time and the
patterns in which that time is accumulated. Traditionally,
clinicians focus on encouraging their patients to exercise
more and increase physical activity with little focus specifi-
cally on sitting time. We are entering a new phase of public
health focus that could change the physician-patient coun-
seling encounter. The recent 2018 Physical Activity Guide-
lines, an update from 2008, have included some preliminary
recommendations on the reduction of sedentary time. Our
data, in addition to the previous literature, demonstrate the
importance of total sitting time and sitting patterns on
important cardiometabolic risk factors that can be directly
addressed in the clinical setting.
Conclusions
Using validated machine-learned algorithms to measure
“sitting,” our results highlight ethnic differences in sitting
behaviors and suggest that associations of sitting patterns
and fasting glucose vary by ethnicity, with more deleterious
associations observed for Hispanic women. Intervention and
longitudinal cohort studies with repeated measurements are
needed to determine if changes in sitting behavior affect
cardiometabolic biomarkers and are modified by ethnicity.
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Table S1. Associations of total sitting time and sitting pattern with additional cardiometabolic 
risk biomarkers. 
 Total sitting time
* Mean sitting bout duration 
 % difference
† (95% CI) P-value % difference† (95% CI) P-value 
HOMA2-IR      
Model 1 6.62 (3.21-10.14) <0.001 7.05 (1.89-12.49) 0.007 
Model 2 6.63 (3.15-10.22) <0.001 7.73 (2.54-13.18) 0.003 
Model 3a 5.36 (1.74-9.1) 0.004 6.21 (1.00-11.68) 0.019 
Model 3b 4.14 (0.88-7.5) 0.013 5.03 (0.23-10.05) 0.040 
Total Cholesterol      
Model 1 0.93 (-0.59-2.46) 0.233 1.31 (-1.00-3.68) 0.269 
Model 2 0.31 (-1.33-1.98) 0.714 1.40 (-1.05-3.90) 0.266 
Model 3a 0.35 (-1.41-2.13) 0.701 1.44 (-1.05-4.00) 0.260 
Model 3b 0.33 (-1.33-2.01) 0.702 1.41 (-1.04-3.93) 0.263 
LDL Cholesterol      
Model 1 1.17 (-1.21-3.59) 0.340 1.94 (-1.66-5.69) 0.296 
Model 2 0.62 (-1.96-3.27) 0.643 2.41 (-1.45-6.42) 0.226 
Model 3a 0.74 (-2.02-3.59) 0.602 2.52 (-1.41-6.62) 0.214 
Model 3b 0.46 (-2.13-3.12) 0.730 2.29 (-1.56-6.31) 0.249 
HDL Cholesterol      
Model 1 -0.98 (-2.96-1.04) 0.342 -2.16 (-5.12-0.90) 0.166 
Model 2 -1.84 (-3.92-0.28) 0.090 -2.68 (-5.73-0.45) 0.094 
Model 3a -1.85 (-4.08-0.42) 0.111 -2.61 (-5.71-0.60) 0.111 
Model 3b -1.63 (-3.71-0.50) 0.134 -2.51 (-5.54-0.62) 0.116 
Triglycerides      
Model 1 4.05 (0.22-8.03) 0.039 5.38 (-0.50-11.6) 0.075 
Model 2 4.86 (0.68-9.21) 0.023 6.12 (-0.11-12.74) 0.056 
Model 3a 4.12 (-0.3-8.75) 0.070 5.31 (-0.97-11.99) 0.101 
Model 3b 4.88 (0.67-9.27) 0.024 6.11 (-0.15-12.76) 0.057 
HOMA2-IR=Algorithm-based calculation of homeostatic model assessment of insulin resistance; 
LDL=low-density lipoprotein; HDL=high-density lipoprotein 
* Adjusted for accelerometer wear time using the residuals method 
† Estimates reflect the percentage difference in the geometric mean of each biomarker associated 
with a 60-minute increase in total sitting time or a 15-minute increase in mean sitting bout 
duration 
Model 1 [n=511] is adjusted for age and device wear time 
Model 2 [n=510] is adjusted for Model 1+education, marital status, physical functioning, ethnicity, 
and parent study 
Model 3a [n=510] is adjusted for Model 2+MVPA    
Model 3b [n=510] is adjusted for Model 2+BMI    
 
 
 
